This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Glaucoma secondary to other eye disorders
DOID EFO MESH SNOMED Endpoint Browser
H7_GLAUCSECDISEASE
open-angle glaucoma: Chronic outflow obstruction of the eye's drainage canals that can lead to increased internal eye pressure and optic nerve damage.
Endpoint definition
↥
FinnGen phenotype data
429209 individuals
Apply sex-specific rule None
429209
Check conditions None
429209
Check pre-conditions, main-only, mode, registry filters
Hospital Discharge: ICD-10
H40.5
Hospital discharge: ICD-9
3655|3656A
Cause of death: ICD-10
H40.5
Cause of death: ICD-9
3655|3656A
2 out of 7 registries used, show all original rules.
1262
Check minimum number of events None
1262
Include endpoints None
1262
Remove individuals based on genotype QC
1211
H7_GLAUCSECDISEASE
Control definitions
Control exclude
H7_GLAUCOMA
Extra metadata
Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
H40
Name in latin
Glaucoma [secundarium] post aliam morbositatem oculi
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to
Glaucoma secondary to other eye disorders
based on the number of shared cases.
Broader endpoints:
Narrower endpoints:
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1211 | 567 | 644 |
| Unadjusted prevalence (%) | 0.29 | 0.25 | 0.35 |
| Mean age at first event (years) | 60.26 | 56.99 | 63.15 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: H7_GLAUCSECDISEASE – Glaucoma secondary to other eye disorders
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Glaucoma secondary to other eye disorders
↥Endpoint not on priority list, no data to show.